Sfoglia per RIVISTA
VASCULAR PHARMACOLOGY
Collezione AOU Novara
Items : 4
Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology. in Vascular pharmacology / Vascul Pharmacol. 2023 Feb;148:107137. doi: 10.1016/j.vph.2022.107137. Epub 2022 Dec 1.
2023
AOU Novara
Patti G; Cavallari I; Cesaro A; Gragnano F; Riva L; Fimiani F; Cuccia C; Fresco C; Calabrò P; Leonardi S; Marcucci R; Rubboli A;
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies. in Vascular pharmacology / Vascul Pharmacol. 2020 Dec;135:106805. doi: 10.1016/j.vph.2020.106805. Epub 2020 Sep 28.
2020
AOU Novara
Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. in Vascular pharmacology / Vascul Pharmacol. 2017 Aug;93-95:42-47. doi: 10.1016/j.vph.2017.04.001. Epub 2017 Apr 19.
2017
AOU Novara
Verdoia M; Daffara V; Pergolini P; Rolla R; Marino P; Bellomo G; Carriero A; De Luca G;
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor. in Vascular pharmacology / Vascul Pharmacol. 2016 Apr;79:11-15. doi: 10.1016/j.vph.2015.10.006. Epub 2015 Oct 28.
2016
AOU Novara
Barbieri L; Pergolini P; Verdoia M; Rolla R; Nardin M; Marino P; Bellomo G; Suryapranata H; De Luca G;